Camden National Corp director Larry K. Haynes received a stock grant as part of his board compensation. On 2026-06-18, he acquired 279 shares of common stock at $51.49 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
Following this grant, Haynes directly holds 1,198 common shares and indirectly holds 3,217.888 common shares through a revocable trust. This reflects a routine, compensation-related equity award rather than an open-market purchase or sale.
Camden National Corporation has furnished an investor presentation outlining its business profile, strategy, and recent financial trends. The bank reports a high-value franchise with $7.0 billion in assets, $5.0 billion in loans, and $5.6 billion in deposits as of March 31, 2026.
The presentation highlights a diversified loan book, with 45% of loans adjustable or variable rate and a loan-to-deposit ratio of 89%. Net interest margin on a fully tax-equivalent basis reached 2.92% in the first quarter of 2026, while core net interest margin was also 2.92%, both up year over year.
Management emphasizes a stable, relationship-driven deposit base, with uninsured and uncollateralized deposits at 15% of total deposits, backed by 2.2x available liquidity. Asset quality metrics remain strong, including nonperforming loans at 0.22% of total loans and net charge-offs at 0.04% of average loans as of March 31, 2026.
The company also stresses operating efficiency and capital strength. Non-interest income represents 19% of total revenue, assets under administration reached $2.4 billion, and capital ratios such as a 10.20% CET1 ratio and 14.27% total risk-based capital support dividends of $1.68 per share and ongoing share repurchases.
Soderberg Carl John reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Carl John Soderberg received a grant of 919 shares of Common Stock as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.
The shares were granted at no cash cost and vested immediately on the grant date. Following this award, Soderberg directly holds a total of 104,041.218 shares of Camden National Corp common stock.
McCarthy Marie J reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Marie J. McCarthy received a grant of 919 shares of Common Stock on June 1, 2026 as equity compensation. The award was made under the Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and its amendment, at no cash cost to her.
The shares vested immediately on the grant date. After this grant and prior dividend reinvestments, McCarthy directly holds a total of 16,941.818 Camden National Corp shares, including 275.647 shares accumulated through the company’s dividend reinvestment program since her last filing.
SAWYER ROBIN A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Robin A. Sawyer received a stock grant of 919 shares of Common Stock. The shares were awarded at no cost under the Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date.
Following this award, Sawyer directly holds a total of 11,390.697 Camden National shares. This filing reflects routine equity-based compensation for an independent director rather than an open-market purchase or sale.
Camden National Corp director Raina Maxwell received a stock grant as part of board compensation. On the grant date, Maxwell acquired 919 shares of Common Stock under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment. The shares vested immediately and carried no purchase price to the director, reflecting a compensation award rather than a market purchase.
After this grant and additional dividend reinvestments, Maxwell now directly holds 3,753.818 shares, including 24.132 shares accumulated since the last filing through the company's dividend reinvestment program.
CAMDEN NATIONAL CORP director Larry K. Haynes reported routine equity and ownership updates. On June 1, 2026, he acquired 919 shares of Common Stock at no cost as a stock grant under the Independent Directors' Equity Compensation Program, which vested immediately.
On May 11, 2026, 3,217.888 shares of Common Stock were moved from his direct holdings into a revocable trust, where he serves as trustee and retains voting and dispositive power, so there was no change in his beneficial ownership. Footnotes also note 33.057 additional shares accumulated since the last filing through the company’s dividend reinvestment program.
Merrill Robert D reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Robert D. Merrill received a stock grant of 919 shares of Common Stock as compensation. The shares were granted under the Independent Directors' Equity Compensation Program, which is part of the 2022 Equity and Incentive Plan and its amendment.
The grant carried no purchase price and vested immediately on the grant date, meaning Merrill gained full ownership right away. Following this award, his direct holdings increased to 11,423.8065 shares of Camden National Corp common stock, reflecting a routine, compensation-related equity increase rather than an open-market purchase.
Longley S. Catherine reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director Catherine S. Longley received an equity award of 919 shares of Common Stock under the company’s Independent Directors' Equity Compensation Program, part of the 2022 Equity and Incentive Plan and Amendment. The grant carried no purchase price and vested immediately on the grant date.
Following this award, Longley directly holds a total of 14,512.613 shares of Camden National Corp common stock. This filing reflects routine director compensation rather than an open-market stock purchase or sale.
Page James H reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp director James H. Page received a grant of 919 shares of Common Stock as equity compensation. The shares were awarded under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan and Amendment, and vested immediately on the grant date. After this award, Page directly holds 10,896 shares of Camden National Corp common stock.